Compound ID | 3298
Class: Beta-lactam (cephalosporin) + beta-lactamase inhibitor
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Enterobacterales expressing serine beta-lactamases |
| Combined with other compounds: | Yes |
| Description: | Synthetic compound; drug combination; cephalosporin-type beta-lactam |
| Year first mentioned: | 2022 |
| Highest developmental phase: | Phase 1 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|